Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine

被引:11
|
作者
de Assis, Felipe Lopes
Hoehn, Kenneth B. [2 ]
Zhang, Xiaozhen [1 ]
Kardava, Lela [1 ]
Smith, Connor D. [1 ]
El Merhebi, Omar [1 ]
Buckner, Clarisa M. [1 ]
Trihemasava, Krittin [1 ]
Wang, Wei [1 ]
Seamon, Catherine A. [1 ]
Chen, Vicky [3 ]
Schaughency, Paul [3 ]
Cheung, Foo [4 ]
Martins, Andrew J. [5 ]
Chiang, Chi-, I [6 ]
Li, Yuxing [6 ,7 ,8 ]
Tsang, John S. [4 ,5 ]
Chun, Tae-Wook [1 ]
Kleinstein, Steven H. [2 ,9 ,10 ]
Moir, Susan [1 ]
机构
[1] Natl Inst Allergy & Infect Dis, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA
[2] Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA
[3] Natl Inst Allergy & Infect Dis, Integrated Data Sci Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA
[4] NIH Ctr Human Immunol, NIAID, NIH, Bethesda, MD 20892 USA
[5] NIAID, Multiscale Syst Biol Sect, Lab Immune Syst Biol, NIH, Bethesda, MD 20892 USA
[6] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA
[7] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA
[8] Univ Maryland, Ctr Biomol Therapeut, Sch Med, Baltimore, MD 21201 USA
[9] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06511 USA
[10] Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
来源
CELL REPORTS | 2023年 / 42卷 / 07期
关键词
MEMORY; IMMUNOGLOBULIN; REVEALS;
D O I
10.1016/j.celrep.2023.112780
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Protective immunity following vaccination is sustained by long-lived antibody-secreting cells and resting memory B cells (MBCs). Responses to two-dose SARS-CoV-2 mRNA-1273 vaccination are evaluated longi-tudinally by multimodal single-cell analysis in three infection-naive individuals. Integrated surface protein, transcriptomics, and B cell receptor (BCR) repertoire analysis of sorted plasmablasts and spike+ (S-2P+) and S -2P- B cells reveal clonal expansion and accumulating mutations among S-2P+ cells. These cells are enriched in a cluster of immunoglobulin G-expressing MBCs and evolve along a bifurcated trajectory rooted in CXCR3+ MBCs. One branch leads to CD11c+ atypical MBCs while the other develops from CD71+ activated precursors to resting MBCs, the dominant population at month 6. Among 12 evolving S-2P+ clones, several are populated with plasmablasts at early timepoints as well as CD71+ activated and resting MBCs at later timepoints, and display intra-and/or inter-cohort BCR convergence. These relationships suggest a coordi-nated and predictable evolution of SARS-CoV-2 vaccine-generated MBCs.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
    Blumenthal, Kimberly G.
    Freeman, Esther E.
    Saff, Rebecca R.
    Robinson, Lacey B.
    Wolfson, Anna R.
    Foreman, Ruth K.
    Hashimoto, Dean
    Banerji, Aleena
    Li, Lily
    Anvari, Sara
    Shenoy, Erica S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1273 - 1277
  • [22] Radiation recall phenomenon after administration of the mRNA-1273 SARS-CoV-2 vaccine
    Ishikawa, Yojiro
    Umezawa, Rei
    Yamamoto, Takaya
    Takahashi, Noriyoshi
    Takeda, Kazuya
    Suzuki, Yu
    Jingu, Keiichi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2022, 11 (01) : 91 - 95
  • [23] Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
    Karakizlis, Hristos
    Agarwal, Vipul
    Aly, Mostafa
    Strecker, Kevin
    Csala, Benjamin
    Esso, Isla
    Chen, Jiangping
    Nahrgang, Christian
    Wolter, Martin
    Slanina, Heiko
    Schuettler, Christian G.
    Jessen, Soenke
    Ronco, Claudio
    Seeger, Werner
    Weimer, Rolf
    Sester, Martina
    Birk, Horst-Walter
    Husain-Syed, Faeq
    JOURNAL OF NEPHROLOGY, 2023, 36 (01) : 183 - 186
  • [24] Atrial fibrillation as a precursor of mRNA-1273 SARS-CoV-2 vaccine-induced pericarditis
    Scheuermeyer, Frank X.
    Yoo, Jeff
    Greene, Michael
    O'Donnell, Shannon
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2022, 24 (02) : 230 - 232
  • [25] Immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in cancer patients receiving immunotherapy agents
    Longo Munoz, F.
    Cortes Salgado, A.
    Serrano Domingo, J. J.
    Casado, J. L.
    Vallejo, A.
    Saavedra Serrano, C.
    Chamorro Perez, J.
    Rosero Rodriguez, D. I.
    Velasco, H.
    Martin, A.
    Soria, A.
    Olmedo Garcia, M. E.
    Gomez Rueda, A.
    Lage, Y.
    Alonso Gordoa, T.
    Molina Cerrillo, J.
    Gajate Borau, P.
    Martinez del Frade, I.
    Garrido Lopez, P.
    Carrato-Mena, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1424 - S1424
  • [26] Atrial fibrillation as a precursor of mRNA-1273 SARS-CoV-2 vaccine-induced pericarditis
    Frank X. Scheuermeyer
    Jeff Yoo
    Michael Greene
    Shannon O’Donnell
    Canadian Journal of Emergency Medicine, 2022, 24 : 230 - 232
  • [27] Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
    Corbett, Kizzmekia S.
    Nason, Martha C.
    Flach, Britta
    Gagne, Matthew
    O' Connell, Sarah
    Johnston, Timothy S.
    Shah, Shruti N.
    Edara, Venkata Viswanadh
    Floyd, Katharine
    Lai, Lilin
    McDanal, Charlene
    Francica, Joseph R.
    Flynn, Barbara
    Wu, Kai
    Choi, Angela
    Koch, Matthew
    Abiona, Olubukola M.
    Werner, Anne P.
    Moliva, Juan, I
    Andrew, Shayne F.
    Donaldson, Mitzi M.
    Fintzi, Jonathan
    Flebbe, Dillon R.
    Lamb, Evan
    Noe, Amy T.
    Nurmukhambetova, Saule T.
    Provost, Samantha J.
    Cook, Anthony
    Dodson, Alan
    Faudree, Andrew
    Greenhouse, Jack
    Kar, Swagata
    Pessaint, Laurent
    Porto, Maciel
    Steingrebe, Katelyn
    Valentin, Daniel
    Zouantcha, Serge
    Bock, Kevin W.
    Minai, Mahnaz
    Nagata, Bianca M.
    van de Wetering, Renee
    Boyoglu-Barnum, Seyhan
    Leung, Kwanyee
    Shi, Wei
    Yang, Eun Sung
    Zhang, Yi
    Todd, John-Paul M.
    Wang, Lingshu
    Alvarado, Gabriela S.
    Andersen, Hanne
    SCIENCE, 2021, 373 (6561) : 1325 - +
  • [28] Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine
    Koutlas, Ioannis G.
    Camara, Renee
    Argyris, Prokopios P.
    Davis, Mark Denis P.
    Miller, Daniel D.
    ORAL DISEASES, 2022, 28 : 2612 - 2613
  • [29] Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis
    Reyes-Leiva, David
    Lopez-Contreras, Joaquin
    Moga, Esther
    Pla-Junca, Francesc
    Lynton-Pons, Elionor
    Rojas-Garcia, Ricardo
    Turon-Sans, Janina
    Querol, Luis
    Olive, Montse
    Alvarez-Velasco, Rodrigo
    Caballero-Avila, Marta
    Carbayo, Alvaro
    Vesperinas-Castro, Ana
    Domingo, Pere
    Illa, Isabel
    Gallardo, Eduard
    Cortes-Vicente, Elena
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (04): : E200002
  • [30] Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants
    Pegu, Amarendra
    O'Connell, Sarah
    Schmidt, Stephen D.
    O'Dell, Sijy
    Talana, Chloe A.
    Lai, Lilin
    Albert, Jim
    Anderson, Evan
    Bennett, Hamilton
    Corbett, Kizzmekia S.
    Flach, Britta
    Jackson, Lisa
    Leav, Brett
    Ledgerwood, Julie E.
    Luke, Catherine J.
    Makowski, Mat
    Roberts, Paul C.
    Roederer, Mario
    Rebolledo, Paulina A.
    Rostad, Christina A.
    Rouphael, Nadine G.
    Shi, Wei
    Wang, Lingshu
    Widge, Alicia T.
    Yang, Eun Sung
    Beigel, John H.
    Graham, Barney S.
    Mascola, John R.
    Suthar, Mehul S.
    McDermott, Adrian
    Doria-Rose, Nicole A.
    SCIENCE, 2021, 373 (6561) : 1372 - +